Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-17 · accession 0000899243-22-007216 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-22 | 2022-02-18 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $231.00 | -519 | 53.3K | -1.0% | -$119.9K |
| 2022-02-22 | 2022-02-17 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | F - Tax | $232.51 | -4,114 | 53.6K | -7% | -$956.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-18 | S | D | 120 | $233.48 | 53,104 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $233.48 (range $233.18 to $233.73). |
| 2 | Common | Common Stock | 2022-02-18 | S | D | 80 | $232.04 | 53,224 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $232.04 (range $231.89 to $232.13). |
| 3 | Common | Common Stock | 2022-02-17 | F | D | 4,114 | $232.51 | 53,623 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-18 | S | D | 218 | $229.52 | 53,405 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F2) Open market sales reported on this line occurred at a weighted average price of $229.52 (range $229.05 to $229.97). |
| 5 | Common | Common Stock | 2022-02-18 | S | D | 101 | $230.42 | 53,304 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $230.42 (range $230.05 to $230.75). |